• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Episurf Medical

0.08 SEK

-2.12 %

Less than 1K followers

EPIS B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-2.12 %
-54.93 %
+45.20 %
+124.26 %
+124.26 %
+34.06 %
-87.80 %
-95.07 %
-97.70 %

Episurf Medical is a real estate company with exposure to a diversified portfolio of real estate assets. The company aims to create value growth through the acquisition and management of Nordic properties. The company also has a medical technology business based on the personalized implant Episealer® and associated surgical instruments, which are used to treat cartilage damage in joints. Episurf Medical's headquarters are located in Stockholm, Sweden.

Read more
Market cap
576.65M SEK
Turnover
948.62K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
24.8.
2026

Interim report Q2'26

13.11.
2026

Interim report Q3'26

5.2.
2027

Annual report '26

Regulatory press release30.06.2026 klo 18.15

Correction: Change in number of shares and votes in Episurf Medical

Episurf Medical
Regulatory press release30.06.2026 klo 17.15

Change in number of shares and votes in Episurf Medical

Episurf Medical
Regulatory press release26.06.2026 klo 17.15

Episurf Medical has entered into a financing agreement for the KlaraBo acquisition and closing of the property portfolio takes place on 2 July 2026

Episurf Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release22.06.2026 klo 20.30

Episurf: Conversion of convertibles in a nominal amount of SEK 37,519,480 to 833,766,222 Class B shares

Episurf Medical
Regulatory press release10.06.2026 klo 14.34

Episurf Medical acquires Kuststaden Invest with a property portfolio at an agreed property value of SEK 647 mn

Episurf Medical
Regulatory press release05.06.2026 klo 17.30

Episurf Medical acquires a mixed property portfolio of 30 properties in Södermanland and Östergötland with an agreed property value of SEK 920 mn from Livi Fastigheter AB

Episurf Medical
Regulatory press release04.06.2026 klo 20.30

The Board of Directors of Episurf has resolved on an issue of Class B shares, convertibles and warrants as part of the consideration for the acquisition of property assets

Episurf Medical
Regulatory press release29.05.2026 klo 16.44

Episurf Medical acquires a portfolio of four properties in Uppsala with an agreed property value of SEK 300 mn from Setune

Episurf Medical
Press release26.05.2026 klo 13.00

Episurf Medical acquires properties in Borås

Episurf Medical
Regulatory press release25.05.2026 klo 17.26

Bulletin from Annual General Meeting in Episurf Medical AB (publ)

Episurf Medical
Regulatory press release25.05.2026 klo 11.32

Correction: Missing MAR label in previous press release - Interim Report 1 January - 31 March 2026

Episurf Medical
Regulatory press release25.05.2026 klo 08.00

Interim Report 1 January - 31 March 2026

Episurf Medical
Regulatory press release22.05.2026 klo 08.30

Episurf Medical acquires a real estate portfolio with an agreed property value of SEK 660m from Lilium

Episurf Medical
Press release21.05.2026 klo 14.26

Episurf Medical strengthens its organisation with a Deputy CEO, Christian Oloffson, and Head of Property Management, Petra Widén Lindh

Episurf Medical
Regulatory press release11.05.2026 klo 17.00

Episurf Medical acquires property portfolio with an agreed property value of SEK 845 mn from Botrygg

Episurf Medical
Regulatory press release05.05.2026 klo 09.41

Episurf Medical has entered into letters of intent to acquire four real estate portfolios with a combined agreed property value of approximately SEK 2.6 billion

Episurf Medical
Regulatory press release30.04.2026 klo 12.45

Change in number of shares and votes in Episurf Medical

Episurf Medical
Regulatory press release23.04.2026 klo 18.40

The Board of Directors of Episurf has resolved on an issue of Class B shares as part of the consideration for the acquisition of real estate assets

Episurf Medical
Regulatory press release21.04.2026 klo 09.00

Notice convening the Annual General Meeting of Episurf Medical AB (publ)

Episurf Medical
Regulatory press release20.04.2026 klo 12.00

Episurf Medical initiates dual-track process for its medtech operations

Episurf Medical